Houlihan Lokey
HLI
$135.96
-3.60%
Houlihan Lokey, Inc. is a global investment bank specializing in mergers and acquisitions, capital markets advisory, financial restructuring, and valuation services, operating within the financial capital markets industry. The firm has established itself as a leading independent advisor, particularly renowned for its expertise in middle-market transactions and complex restructurings, distinguishing itself from bulge-bracket peers through its focused advisory model. The current investor narrative centers on the company's resilience and market share gains amid a challenging environment for investment banking activity, with recent financial trends highlighting its ability to grow revenue and maintain profitability despite sector-wide headwinds, positioning it as a defensive play within financial services.…
HLI
Houlihan Lokey
$135.96
Investment Opinion: Should I buy HLI Today?
Rating & Thesis: HLI is a BUY for value-oriented investors seeking a high-quality, financially resilient business trading at a discount due to transient sector fears. The core thesis is that the company's accelerating revenue growth (13.03% YoY) and fortress balance sheet are not reflected in its current depressed price, creating a compelling risk/reward setup as analyst sentiment remains bullish.
Supporting Evidence: The buy case is supported by four key data points: 1) A forward PE of 15.00x, which is a 33% discount to the trailing PE and implies strong earnings growth expectations; 2) Robust free cash flow generation yielding a high FCF yield on the market cap; 3) A net margin of 16.26% that demonstrates durable earnings power; and 4) A valuation (22.45x trailing PE) that has compressed from its 30.75x peak and is now more aligned with historical averages, reducing downside risk.
Risks & Conditions: The two biggest risks are a further slowdown in investment banking activity compressing revenue growth below 10%, and multiple contraction if the premium PE erodes further. This Buy rating would downgrade to Hold if the stock breaks and sustains below the 52-week low of $134.41 on deteriorating volume, or upgrade to a Strong Buy if the forward PE compresses below 13x while quarterly revenue growth holds above 15%. The stock is currently fairly valued relative to its own history but undervalued relative to its growth profile and quality metrics.
Sign up to view all
HLI 12-Month Price Forecast
The AI assessment is cautiously bullish, grounded in the stark divergence between HLI's deteriorating price action and its resilient fundamentals. The confidence is medium due to the clear macro and sector headwinds that could persist. The key is whether the forward PE of 15.00x, implying significant earnings growth, is achievable. The stance would upgrade to high-confidence bullish on a confirmed breakout above the $160 resistance level on strong volume, signaling the downtrend has broken. It would downgrade to neutral if revenue growth decelerates below 5% in the next quarter, indicating the fundamental story is cracking.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Houlihan Lokey's 12-month outlook, with a consensus price target around $176.75 and implied upside of +30.0% versus the current price.
Average Target
$176.75
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$109 - $177
Analyst target range
Analyst coverage for HLI appears limited, with only 3 analysts providing estimates, which is low for a company of its market cap and suggests it may be under-followed by the broader institutional community. The consensus sentiment, inferred from recent institutional ratings, leans bullish, with firms like Goldman Sachs, Morgan Stanley, BMO Capital, and Keefe Bruyette & Woods maintaining 'Buy,' 'Overweight,' or 'Outperform' ratings, while UBS maintains a 'Neutral' stance. The wide range of EPS estimates, from a low of $9.79 to a high of $11.24, signals meaningful uncertainty or divergence in views on the company's near-term earnings power, which can contribute to stock price volatility. The pattern of recent ratings shows stability, with no downgrades in the provided data and one upgrade from Keefe Bruyette & Woods in July 2025, indicating underlying analyst confidence despite the stock's weak price performance.
Bulls vs Bears: HLI Investment Factors
The bull case for HLI is grounded in its demonstrable fundamental strength: accelerating revenue growth, exceptional profitability, and a rock-solid balance sheet that together make it a defensive standout in a weak sector. The bear case is equally compelling on a technical and sentiment basis, with the stock in a severe downtrend, trading at a sector premium, and facing high short interest. Currently, the fundamental evidence appears stronger, suggesting the sell-off is overdone, but the single most important tension in the investment debate is whether HLI's premium valuation (22.45x trailing PE) can be sustained if the broader investment banking cycle fails to recover, potentially leading to multiple compression that overshadows its operational resilience.
Bullish
- Strong Revenue Growth Amid Sector Headwinds: HLI posted 13.03% YoY revenue growth in its latest quarter to $717.07M, accelerating from the prior quarter's $659.45M. This demonstrates the firm's ability to gain market share and grow its top line despite a challenging environment for investment banking activity.
- Exceptional Profitability and Cash Flow: The company maintains a robust net margin of 16.26% and a near-perfect gross margin of 98.37%. It generated $738.94M in trailing twelve-month free cash flow, supporting a healthy dividend with a 40.88% payout ratio and providing significant financial flexibility.
- Fortress Balance Sheet with Minimal Debt: HLI's balance sheet is a key strength, with a low debt-to-equity ratio of 0.21 and a solid current ratio of 1.53. This low leverage provides a significant buffer against economic downturns and funds strategic initiatives without financial strain.
- Analyst Sentiment Remains Bullish: Despite the stock's decline, major institutions like Goldman Sachs and Morgan Stanley maintain 'Buy' or 'Overweight' ratings, with one upgrade noted in July 2025. This underlying confidence suggests the sell-off may be overdone relative to the firm's fundamentals.
Bearish
- Severe Technical Downtrend and Weakness: HLI is in a pronounced downtrend, down 19.06% over the past year and trading at just 9.4% of its 52-week range. It has shown severe relative weakness, declining 13.50% over three months while the S&P 500 gained 10.28%, indicating strong selling pressure.
- High Valuation Premium vs. Financial Sector: With a trailing PE of 22.45x and a PS ratio of 3.65, HLI trades at a premium to many traditional financial services firms. This premium valuation is vulnerable to compression if sector-wide M&A activity remains subdued or growth expectations are not met.
- Limited Analyst Coverage and High Uncertainty: Only 3 analysts provide estimates for HLI, indicating it may be under-followed. The wide EPS estimate range from $9.79 to $11.24 signals significant uncertainty about near-term earnings, which can contribute to stock price volatility and mispricing risk.
- Cyclical Exposure to Investment Banking: As an investment bank, HLI's revenue is inherently tied to the cyclical M&A and capital markets environment. A prolonged downturn in deal activity or a recession could pressure its core Corporate Finance segment, which drove $473.69M of last quarter's revenue.
HLI Technical Analysis
The prevailing price trend for HLI is a pronounced downtrend, with the stock down 19.06% over the past year and currently trading at just 9.4% of its 52-week range, based on a current price of $141.66 relative to a 52-week high of $211.78 and low of $134.41. This positioning near the lower bound of its annual range suggests the stock is deeply oversold, potentially presenting a value opportunity, though it also risks being a 'falling knife' if the fundamental backdrop continues to deteriorate. Recent momentum shows significant acceleration to the downside, with the stock declining 9.19% over the past month and 13.50% over the past three months, a stark divergence from the broader market's gains of 6.31% and 10.28%, respectively, over the same periods, indicating severe relative weakness and capitulation. Key technical support is clearly defined at the 52-week low of $134.41, while resistance sits at the recent breakdown level near the 52-week high of $211.78; a sustained break below support could trigger another leg down, whereas a recovery above it may signal a bottoming process, with the stock's beta of 1.002 indicating market-average volatility that does not amplify the inherent sector risks.
Beta
0.95
0.95x market volatility
Max Drawdown
-35.0%
Largest decline past year
52-Week Range
$134-$212
Price range past year
Annual Return
-21.9%
Cumulative gain past year
| Period | HLI Return | S&P 500 |
|---|---|---|
| 1m | -8.7% | -1.9% |
| 3m | -2.8% | +8.9% |
| 6m | -24.2% | +6.4% |
| 1y | -21.9% | +20.3% |
| ytd | -22.9% | +6.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HLI Fundamental Analysis
Houlihan Lokey's revenue trajectory remains positive, with the most recent quarterly revenue of $717.07 million representing a 13.03% year-over-year growth, and a sequential increase from the prior quarter's $659.45 million, indicating accelerating top-line momentum. Segment data reveals the Corporate Finance business is the primary growth driver, contributing $473.69 million, while Financial Restructuring added $156.25 million, demonstrating balanced strength across its core advisory practices. The company is highly profitable, posting net income of $116.55 million in the latest quarter with a robust net margin of 16.26%, supported by an exceptionally high gross margin of 98.37% typical for a service-based advisory firm. Profitability metrics are stable, with the operating margin at 23.63% and return on equity a healthy 18.17%, indicating efficient use of shareholder capital and durable earnings power. The balance sheet is exceptionally strong, featuring a low debt-to-equity ratio of 0.21 and a solid current ratio of 1.53, providing ample liquidity. Cash flow generation is robust, with trailing twelve-month free cash flow of $738.94 million, translating to a high FCF yield that supports shareholder returns through dividends, evidenced by a payout ratio of 40.88%.
Quarterly Revenue
$717072000.0B
2025-12
Revenue YoY Growth
+0.13%
YoY Comparison
Gross Margin
+1.00%
Latest Quarter
Free Cash Flow
$738939000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HLI Overvalued?
Given HLI's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 22.45x and a forward PE of 15.00x, with the significant discount in the forward multiple implying the market expects substantial earnings growth in the coming year. Compared to sector averages, HLI's trailing PE of 22.45x likely represents a premium to many traditional financial services firms, a spread justified by the company's superior growth profile, high profitability margins, and leading market position in niche advisory services. Historically, the current trailing PE of 22.45x sits below its recent peak of 30.75x from Q2 2026 and is more aligned with its longer-term average, suggesting the recent price decline has brought valuations back to a more reasonable level relative to its own history, reducing the risk of over-optimistic expectations being priced in.
PE
22.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 10x~31x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: HLI's primary financial risk is its cyclical revenue dependence on M&A and restructuring activity, which can be volatile. While the balance sheet is strong with a 0.21 debt-to-equity ratio, a significant and prolonged downturn in deal flow could pressure its high profitability margins, such as the 16.26% net margin. Furthermore, revenue concentration in advisory services (98.37% gross margin) means earnings are highly sensitive to fluctuations in transaction volumes and fee income, with limited diversification into more stable revenue streams.
Market & Competitive Risks: The stock trades at a premium valuation with a trailing PE of 22.45x, which is vulnerable to compression if the market rerates financial services stocks lower or if HLI's growth decelerates. Competitive risks are omnipresent from both bulge-bracket banks and other independent advisors, though HLI's middle-market focus provides some insulation. The stock's beta of 1.002 indicates market-average volatility, but its severe underperformance (-47.27% relative strength over one year) highlights unique sector and company-specific headwinds that are not captured by beta alone.
Worst-Case Scenario: The worst-case scenario involves a deep recession that cripples global M&A activity for multiple quarters, leading to consecutive misses on revenue and earnings estimates. This could trigger analyst downgrades from the current bullish consensus, a derating of the PE multiple towards 15x, and a test of the 52-week low of $134.41. Combined with the high short interest fueling a downward spiral, a realistic downside from the current price of $141.66 could be a decline of 20-25%, bringing the stock into the $106-$113 range, which would represent a drawdown exceeding the recent -33.61% max drawdown.
FAQ
The key risks are: 1) Cyclical/Macro Risk: Revenue is tied to M&A activity, which is sensitive to interest rates and economic confidence. 2) Valuation Risk: The premium trailing PE of 22.45x could compress if growth slows. 3) Sentiment Risk: High short interest (short ratio 2.71) and severe technical downtrend can perpetuate selling pressure regardless of fundamentals. 4) Coverage Risk: With only 3 analysts, the stock may be less liquid and more prone to mispricing. The cyclical risk is currently the most severe, as it directly impacts the core business model.
The 12-month forecast for HLI is scenario-dependent. The base case (50% probability) sees the stock trading between $155 and $175, driven by stable execution and a rerating towards its forward PE. The bull case (30% probability) targets $190 to $211 on a sharp M&A recovery. The bear case (20% probability) warns of a drop to $115-$134 if the sector downturn deepens. The base case is most likely, assuming the company continues to post modest growth while navigating a challenging environment, with the stock gradually recovering as pessimism peaks.
HLI's valuation presents a mixed picture. Its trailing PE of 22.45x is at a premium to many financial stocks, justified by its superior growth and margins. However, its forward PE of 15.00x represents a significant discount and suggests the market expects strong earnings growth. Historically, the current multiple is below its recent peak of 30.75x. Relative to its own high-quality fundamentals and growth trajectory, the stock appears fairly valued to slightly undervalued, especially after its steep decline. The market is pricing in a recovery that has yet to materialize in the share price.
HLI presents a compelling opportunity for investors with a medium-to-long-term horizon who are comfortable with sector cyclicality. The stock is down 19% over the past year and trades near its 52-week low, but fundamentals remain strong with 13% revenue growth and a 16% net margin. The primary risk is that the investment banking downturn persists, compressing its premium valuation further. It is a good buy for value investors seeking quality at a discount, but not for those seeking short-term momentum or immune to financial sector volatility.
HLI is far more suitable for a long-term investment horizon of 2-3 years minimum. Its business is cyclical, and waiting for a turn in the M&A cycle requires patience. The stock's high beta (1.002) and recent volatility make it a poor short-term trading vehicle, as sentiment can overshadow fundamentals. For long-term investors, the current price offers a chance to buy a financially robust market leader at a discount. The dividend, while modest at a 1.82% yield, adds an element of income for holders willing to wait for capital appreciation.